ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Temporal Arteritis Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19R13493
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Temporal Arteritis Market Insights Forecast to 2029
BUY CHAPTERS

Global Temporal Arteritis Market Research Report 2025

Code: QYRE-Auto-19R13493
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Endo International, Inc.
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Ltd
Dr. Reddy’s Laboratories Ltd.
Abbott
F Hoffmann La Roche Ltd
Pfizer Inc
Zydus Group
Lupin Ltd
Amorphex Therapeutics Holdings, Inc
Bausch Health Companies Inc.
Regeneron Pharmaceuticals Inc
Astellas Pharma Inc

Temporal Arteritis Market

The global market for Temporal Arteritis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Temporal arteritis is also known as Horton"s arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis.
North American market for Temporal Arteritis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Temporal Arteritis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Temporal Arteritis include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd, Pfizer Inc, Zydus Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Temporal Arteritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Temporal Arteritis.
The Temporal Arteritis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Temporal Arteritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Temporal Arteritis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Temporal Arteritis Market Report

Report Metric Details
Report Name Temporal Arteritis Market
Segment by Type
  • Oral
  • Parenteral
Segment by Application
  • Hospital
  • Home Care
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd, Pfizer Inc, Zydus Group, Lupin, Amorphex Therapeutics Holdings, Inc, Bausch Health Companies Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Temporal Arteritis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Temporal Arteritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Temporal Arteritis Market report?

Ans: The main players in the Temporal Arteritis Market are Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd, Pfizer Inc, Zydus Group, Lupin, Amorphex Therapeutics Holdings, Inc, Bausch Health Companies Inc, Regeneron Pharmaceuticals Inc, Astellas Pharma Inc

What are the Application segmentation covered in the Temporal Arteritis Market report?

Ans: The Applications covered in the Temporal Arteritis Market report are Hospital, Home Care, Other

What are the Type segmentation covered in the Temporal Arteritis Market report?

Ans: The Types covered in the Temporal Arteritis Market report are Oral, Parenteral

1 Temporal Arteritis Market Overview
1.1 Product Definition
1.2 Temporal Arteritis by Type
1.2.1 Global Temporal Arteritis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Parenteral
1.3 Temporal Arteritis by Application
1.3.1 Global Temporal Arteritis Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Home Care
1.3.4 Other
1.4 Global Temporal Arteritis Market Size Estimates and Forecasts
1.4.1 Global Temporal Arteritis Revenue 2020-2031
1.4.2 Global Temporal Arteritis Sales 2020-2031
1.4.3 Global Temporal Arteritis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Temporal Arteritis Market Competition by Manufacturers
2.1 Global Temporal Arteritis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Temporal Arteritis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Temporal Arteritis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Temporal Arteritis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Temporal Arteritis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Temporal Arteritis, Product Type & Application
2.7 Global Key Manufacturers of Temporal Arteritis, Date of Enter into This Industry
2.8 Global Temporal Arteritis Market Competitive Situation and Trends
2.8.1 Global Temporal Arteritis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Temporal Arteritis Players Market Share by Revenue
2.8.3 Global Temporal Arteritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Temporal Arteritis Market Scenario by Region
3.1 Global Temporal Arteritis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Temporal Arteritis Sales by Region: 2020-2031
3.2.1 Global Temporal Arteritis Sales by Region: 2020-2025
3.2.2 Global Temporal Arteritis Sales by Region: 2026-2031
3.3 Global Temporal Arteritis Revenue by Region: 2020-2031
3.3.1 Global Temporal Arteritis Revenue by Region: 2020-2025
3.3.2 Global Temporal Arteritis Revenue by Region: 2026-2031
3.4 North America Temporal Arteritis Market Facts & Figures by Country
3.4.1 North America Temporal Arteritis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Temporal Arteritis Sales by Country (2020-2031)
3.4.3 North America Temporal Arteritis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Temporal Arteritis Market Facts & Figures by Country
3.5.1 Europe Temporal Arteritis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Temporal Arteritis Sales by Country (2020-2031)
3.5.3 Europe Temporal Arteritis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Temporal Arteritis Market Facts & Figures by Region
3.6.1 Asia Pacific Temporal Arteritis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Temporal Arteritis Sales by Region (2020-2031)
3.6.3 Asia Pacific Temporal Arteritis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Temporal Arteritis Market Facts & Figures by Country
3.7.1 Latin America Temporal Arteritis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Temporal Arteritis Sales by Country (2020-2031)
3.7.3 Latin America Temporal Arteritis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Temporal Arteritis Market Facts & Figures by Country
3.8.1 Middle East and Africa Temporal Arteritis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Temporal Arteritis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Temporal Arteritis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Temporal Arteritis Sales by Type (2020-2031)
4.1.1 Global Temporal Arteritis Sales by Type (2020-2025)
4.1.2 Global Temporal Arteritis Sales by Type (2026-2031)
4.1.3 Global Temporal Arteritis Sales Market Share by Type (2020-2031)
4.2 Global Temporal Arteritis Revenue by Type (2020-2031)
4.2.1 Global Temporal Arteritis Revenue by Type (2020-2025)
4.2.2 Global Temporal Arteritis Revenue by Type (2026-2031)
4.2.3 Global Temporal Arteritis Revenue Market Share by Type (2020-2031)
4.3 Global Temporal Arteritis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Temporal Arteritis Sales by Application (2020-2031)
5.1.1 Global Temporal Arteritis Sales by Application (2020-2025)
5.1.2 Global Temporal Arteritis Sales by Application (2026-2031)
5.1.3 Global Temporal Arteritis Sales Market Share by Application (2020-2031)
5.2 Global Temporal Arteritis Revenue by Application (2020-2031)
5.2.1 Global Temporal Arteritis Revenue by Application (2020-2025)
5.2.2 Global Temporal Arteritis Revenue by Application (2026-2031)
5.2.3 Global Temporal Arteritis Revenue Market Share by Application (2020-2031)
5.3 Global Temporal Arteritis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Temporal Arteritis Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Endo International Inc
6.2.1 Endo International Inc Company Information
6.2.2 Endo International Inc Description and Business Overview
6.2.3 Endo International Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Endo International Inc Temporal Arteritis Product Portfolio
6.2.5 Endo International Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Company Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Glenmark Pharmaceuticals Ltd
6.4.1 Glenmark Pharmaceuticals Ltd Company Information
6.4.2 Glenmark Pharmaceuticals Ltd Description and Business Overview
6.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Portfolio
6.4.5 Glenmark Pharmaceuticals Ltd Recent Developments/Updates
6.5 Cipla Inc
6.5.1 Cipla Inc Company Information
6.5.2 Cipla Inc Description and Business Overview
6.5.3 Cipla Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Inc Temporal Arteritis Product Portfolio
6.5.5 Cipla Inc Recent Developments/Updates
6.6 Dr Reddy's Laboratories Ltd
6.6.1 Dr Reddy's Laboratories Ltd Company Information
6.6.2 Dr Reddy's Laboratories Ltd Description and Business Overview
6.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Portfolio
6.6.5 Dr Reddy's Laboratories Ltd Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Temporal Arteritis Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 F. Hoffmann -La Roche Ltd
6.8.1 F. Hoffmann -La Roche Ltd Company Information
6.8.2 F. Hoffmann -La Roche Ltd Description and Business Overview
6.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Portfolio
6.8.5 F. Hoffmann -La Roche Ltd Recent Developments/Updates
6.9 Pfizer Inc
6.9.1 Pfizer Inc Company Information
6.9.2 Pfizer Inc Description and Business Overview
6.9.3 Pfizer Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Inc Temporal Arteritis Product Portfolio
6.9.5 Pfizer Inc Recent Developments/Updates
6.10 Zydus Group
6.10.1 Zydus Group Company Information
6.10.2 Zydus Group Description and Business Overview
6.10.3 Zydus Group Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zydus Group Temporal Arteritis Product Portfolio
6.10.5 Zydus Group Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Company Information
6.11.2 Lupin Description and Business Overview
6.11.3 Lupin Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lupin Temporal Arteritis Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 Amorphex Therapeutics Holdings, Inc
6.12.1 Amorphex Therapeutics Holdings, Inc Company Information
6.12.2 Amorphex Therapeutics Holdings, Inc Description and Business Overview
6.12.3 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product Portfolio
6.12.5 Amorphex Therapeutics Holdings, Inc Recent Developments/Updates
6.13 Bausch Health Companies Inc
6.13.1 Bausch Health Companies Inc Company Information
6.13.2 Bausch Health Companies Inc Description and Business Overview
6.13.3 Bausch Health Companies Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bausch Health Companies Inc Temporal Arteritis Product Portfolio
6.13.5 Bausch Health Companies Inc Recent Developments/Updates
6.14 Regeneron Pharmaceuticals Inc
6.14.1 Regeneron Pharmaceuticals Inc Company Information
6.14.2 Regeneron Pharmaceuticals Inc Description and Business Overview
6.14.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Portfolio
6.14.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
6.15 Astellas Pharma Inc
6.15.1 Astellas Pharma Inc Company Information
6.15.2 Astellas Pharma Inc Description and Business Overview
6.15.3 Astellas Pharma Inc Temporal Arteritis Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Astellas Pharma Inc Temporal Arteritis Product Portfolio
6.15.5 Astellas Pharma Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Temporal Arteritis Industry Chain Analysis
7.2 Temporal Arteritis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Temporal Arteritis Production Mode & Process Analysis
7.4 Temporal Arteritis Sales and Marketing
7.4.1 Temporal Arteritis Sales Channels
7.4.2 Temporal Arteritis Distributors
7.5 Temporal Arteritis Customer Analysis
8 Temporal Arteritis Market Dynamics
8.1 Temporal Arteritis Industry Trends
8.2 Temporal Arteritis Market Drivers
8.3 Temporal Arteritis Market Challenges
8.4 Temporal Arteritis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Endo International, Inc.
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Ltd
Dr. Reddy’s Laboratories Ltd.
Abbott
F Hoffmann La Roche Ltd
Pfizer Inc
Zydus Group
Lupin Ltd
Amorphex Therapeutics Holdings, Inc
Bausch Health Companies Inc.
Regeneron Pharmaceuticals Inc
Astellas Pharma Inc
List of Tables
 Table 1. Global Temporal Arteritis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Temporal Arteritis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Temporal Arteritis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Temporal Arteritis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Temporal Arteritis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Temporal Arteritis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Temporal Arteritis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Temporal Arteritis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Temporal Arteritis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Temporal Arteritis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Temporal Arteritis, Product Type & Application
 Table 12. Global Key Manufacturers of Temporal Arteritis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Temporal Arteritis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Temporal Arteritis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Temporal Arteritis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Temporal Arteritis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Temporal Arteritis Sales Market Share by Region (2020-2025)
 Table 19. Global Temporal Arteritis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Temporal Arteritis Sales Market Share by Region (2026-2031)
 Table 21. Global Temporal Arteritis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Temporal Arteritis Revenue Market Share by Region (2020-2025)
 Table 23. Global Temporal Arteritis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Temporal Arteritis Revenue Market Share by Region (2026-2031)
 Table 25. North America Temporal Arteritis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Temporal Arteritis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Temporal Arteritis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Temporal Arteritis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Temporal Arteritis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Temporal Arteritis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Temporal Arteritis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Temporal Arteritis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Temporal Arteritis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Temporal Arteritis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Temporal Arteritis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Temporal Arteritis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Temporal Arteritis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Temporal Arteritis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Temporal Arteritis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Temporal Arteritis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Temporal Arteritis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Temporal Arteritis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Temporal Arteritis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Temporal Arteritis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Temporal Arteritis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Temporal Arteritis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Temporal Arteritis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Temporal Arteritis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Temporal Arteritis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Temporal Arteritis Sales (K Units) by Type (2020-2025)
 Table 51. Global Temporal Arteritis Sales (K Units) by Type (2026-2031)
 Table 52. Global Temporal Arteritis Sales Market Share by Type (2020-2025)
 Table 53. Global Temporal Arteritis Sales Market Share by Type (2026-2031)
 Table 54. Global Temporal Arteritis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Temporal Arteritis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Temporal Arteritis Revenue Market Share by Type (2020-2025)
 Table 57. Global Temporal Arteritis Revenue Market Share by Type (2026-2031)
 Table 58. Global Temporal Arteritis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Temporal Arteritis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Temporal Arteritis Sales (K Units) by Application (2020-2025)
 Table 61. Global Temporal Arteritis Sales (K Units) by Application (2026-2031)
 Table 62. Global Temporal Arteritis Sales Market Share by Application (2020-2025)
 Table 63. Global Temporal Arteritis Sales Market Share by Application (2026-2031)
 Table 64. Global Temporal Arteritis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Temporal Arteritis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Temporal Arteritis Revenue Market Share by Application (2020-2025)
 Table 67. Global Temporal Arteritis Revenue Market Share by Application (2026-2031)
 Table 68. Global Temporal Arteritis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Temporal Arteritis Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis AG Temporal Arteritis Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Endo International Inc Company Information
 Table 76. Endo International Inc Description and Business Overview
 Table 77. Endo International Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Endo International Inc Temporal Arteritis Product
 Table 79. Endo International Inc Recent Developments/Updates
 Table 80. Teva Pharmaceutical Industries Ltd Company Information
 Table 81. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 82. Teva Pharmaceutical Industries Ltd Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Pharmaceutical Industries Ltd Temporal Arteritis Product
 Table 84. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 85. Glenmark Pharmaceuticals Ltd Company Information
 Table 86. Glenmark Pharmaceuticals Ltd Description and Business Overview
 Table 87. Glenmark Pharmaceuticals Ltd Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Glenmark Pharmaceuticals Ltd Temporal Arteritis Product
 Table 89. Glenmark Pharmaceuticals Ltd Recent Developments/Updates
 Table 90. Cipla Inc Company Information
 Table 91. Cipla Inc Description and Business Overview
 Table 92. Cipla Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cipla Inc Temporal Arteritis Product
 Table 94. Cipla Inc Recent Developments/Updates
 Table 95. Dr Reddy's Laboratories Ltd Company Information
 Table 96. Dr Reddy's Laboratories Ltd Description and Business Overview
 Table 97. Dr Reddy's Laboratories Ltd Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dr Reddy's Laboratories Ltd Temporal Arteritis Product
 Table 99. Dr Reddy's Laboratories Ltd Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Abbott Temporal Arteritis Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. F. Hoffmann -La Roche Ltd Company Information
 Table 106. F. Hoffmann -La Roche Ltd Description and Business Overview
 Table 107. F. Hoffmann -La Roche Ltd Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. F. Hoffmann -La Roche Ltd Temporal Arteritis Product
 Table 109. F. Hoffmann -La Roche Ltd Recent Developments/Updates
 Table 110. Pfizer Inc Company Information
 Table 111. Pfizer Inc Description and Business Overview
 Table 112. Pfizer Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Inc Temporal Arteritis Product
 Table 114. Pfizer Inc Recent Developments/Updates
 Table 115. Zydus Group Company Information
 Table 116. Zydus Group Description and Business Overview
 Table 117. Zydus Group Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zydus Group Temporal Arteritis Product
 Table 119. Zydus Group Recent Developments/Updates
 Table 120. Lupin Company Information
 Table 121. Lupin Description and Business Overview
 Table 122. Lupin Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Lupin Temporal Arteritis Product
 Table 124. Lupin Recent Developments/Updates
 Table 125. Amorphex Therapeutics Holdings, Inc Company Information
 Table 126. Amorphex Therapeutics Holdings, Inc Description and Business Overview
 Table 127. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Amorphex Therapeutics Holdings, Inc Temporal Arteritis Product
 Table 129. Amorphex Therapeutics Holdings, Inc Recent Developments/Updates
 Table 130. Bausch Health Companies Inc Company Information
 Table 131. Bausch Health Companies Inc Description and Business Overview
 Table 132. Bausch Health Companies Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Bausch Health Companies Inc Temporal Arteritis Product
 Table 134. Bausch Health Companies Inc Recent Developments/Updates
 Table 135. Regeneron Pharmaceuticals Inc Company Information
 Table 136. Regeneron Pharmaceuticals Inc Description and Business Overview
 Table 137. Regeneron Pharmaceuticals Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Regeneron Pharmaceuticals Inc Temporal Arteritis Product
 Table 139. Regeneron Pharmaceuticals Inc Recent Developments/Updates
 Table 140. Astellas Pharma Inc Company Information
 Table 141. Astellas Pharma Inc Description and Business Overview
 Table 142. Astellas Pharma Inc Temporal Arteritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Astellas Pharma Inc Temporal Arteritis Product
 Table 144. Astellas Pharma Inc Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Temporal Arteritis Distributors List
 Table 148. Temporal Arteritis Customers List
 Table 149. Temporal Arteritis Market Trends
 Table 150. Temporal Arteritis Market Drivers
 Table 151. Temporal Arteritis Market Challenges
 Table 152. Temporal Arteritis Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Temporal Arteritis
 Figure 2. Global Temporal Arteritis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Temporal Arteritis Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Parenteral Product Picture
 Figure 6. Global Temporal Arteritis Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Temporal Arteritis Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Home Care
 Figure 10. Other
 Figure 11. Global Temporal Arteritis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Temporal Arteritis Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Temporal Arteritis Sales (2020-2031) & (K Units)
 Figure 14. Global Temporal Arteritis Average Price (US$/Unit) & (2020-2031)
 Figure 15. Temporal Arteritis Report Years Considered
 Figure 16. Temporal Arteritis Sales Share by Manufacturers in 2024
 Figure 17. Global Temporal Arteritis Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Temporal Arteritis Players: Market Share by Revenue in Temporal Arteritis in 2024
 Figure 19. Temporal Arteritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Temporal Arteritis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Temporal Arteritis Sales Market Share by Country (2020-2031)
 Figure 22. North America Temporal Arteritis Revenue Market Share by Country (2020-2031)
 Figure 23. United States Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Temporal Arteritis Sales Market Share by Country (2020-2031)
 Figure 26. Europe Temporal Arteritis Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Temporal Arteritis Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Temporal Arteritis Revenue Market Share by Region (2020-2031)
 Figure 34. China Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Temporal Arteritis Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Temporal Arteritis Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Temporal Arteritis Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Temporal Arteritis Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Temporal Arteritis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Temporal Arteritis by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Temporal Arteritis by Type (2020-2031)
 Figure 53. Global Temporal Arteritis Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Temporal Arteritis by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Temporal Arteritis by Application (2020-2031)
 Figure 56. Global Temporal Arteritis Price (US$/Unit) by Application (2020-2031)
 Figure 57. Temporal Arteritis Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Giant Cell Arteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Giant Cell Arteritis Therapeutic Market Research Report 2024
Blepharitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blepharitis Therapeutics Market Research Report 2025
Global Renal Cortical Necrosis Treatment Market Research Report 2025
Buerger s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Fatigue Syndrome Treatment Market Insights Forecast to 2030
Chronic Fatigue Syndrome Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ICAD Intracranial Atherosclerotic Disease Pathology Market Insights Forecast to 2030
Global Cerebral Infarction Therapy Market Insights Forecast to 2030
Global Chronic Fatigue Syndrome Therapeutics Drug Market Research Report 2024
Global Poly Myalgia Rheumatica Treatment Market Research Report 2024
Global Retinal Vasculitis Treatment Market Research Report 2025
Global Rosacea Therapeutics Market Insights Forecast to 2030
Global Scalp Anti Aging Shampoo Market Insights Forecast to 2030
Global Ataxia telangiectasia AT Treatment Market Research Report 2025
Chronic Focal Encephalitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Crohn s Disease Market Research Report 2024
Global Cerebrovascular Disease Market Research Report 2024
Global Traumatic Brain Injury Therapeutics Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions